Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: Anbio Biotechnology(NNNN) the Revenue is 2.031 M (+73.93%);the EBIT is 1.2 M (+249.8%);the EPS is 0.0297 (+305.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B73.93%
----
----
EBIT
0.00B249.75%
----
----
EPS
0.0297305.14%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf